Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ertugliflozin (Steglatro) (1 trial)
anidulafungin (eraxis) (1 trial)
doxorubicin (Doxil) (1 trial)
etelcalcetide (parsabiv) (1 trial)
fsme-immun (1 trial)
lapatinib (tykerb) (1 trial)
sodium bicarbonate (1 trial)
sucroferric oxyhydroxide (velphoro) (1 trial)
Breast Neoplasms (Phase 2)
Calcinosis (Phase 2)
Encephalitis (Phase 2)
Encephalitis, Tick-Borne (Phase 2)
Kidney Failure, Chronic (Phase 2)
Neoplasms (Phase 2)
Trials (7 total)
Trial APIs (8 total)